Press Releases

For Immediate Release

San Juan Capistrano, CA – September 10, 2020

Ellipsys System Offers Greater Patient Eligibility and Reduced Time to Dialysis

First study to compare percutaneous arteriovenous fistula devices reports positive clinical outcomes

For Immediate Release

North Chesterfield, VA – September 3, 2020

Minimally Invasive Ellipsys System Allows Kidney Patients to Begin Dialysis Sooner with Fewer Interventions

New study has important patient safety implications, as shortening dialysis timeline reduces reliance on riskier vascular access procedures

For Immediate Release

San Juan Capistrano, CA – July 21, 2020

New Study Shows Advantages of Ellipsys System in Safely and Quickly Creating Reliable Dialysis Access

Large study in Journal of Vascular Surgery offers roadmap for more widespread use of percutaneous fistula creation

For Immediate Release

San Juan Capistrano, CA – March 3, 2020

Ellipsys System Offers Significant Advantages for Creating Dialysis Access, Physicians Say

Dr. Jeffrey Hull Awarded First Place for Presentation at 16th Annual ASDIN Meeting

For Immediate Release

San Juan Capistrano, CA – December 18, 2019

Two-year Ellipsys data featured at annual Controversies in Dialysis Access (CiDA) Meeting

Innovative endoAVF technology is a ‘true paradigm shift’ in dialysis access, leading physicians say

For Immediate Release

Blanchardville, WI – December 5, 2019

Kidney Patients Report Positive Experiences with Novel Approach to Dialysis Access

Landmark study reports greater success with minimally invasive vascular access procedure

For Immediate Release

Tempe, AZ – December 6, 2018

SKI Vascular Center is First Ambulatory Surgical Center in the Nation to Utilize FDA-Approved Ellipsys System for Non-Surgical Dialysis Fistula Creation

Local Interventional Nephrologists Randy Cooper, MD and Umar Waheed, MD, Pioneer Breakthrough Endovascular Arteriovenous Fistula (endoAVF®) Technology for ESRD Patients

For Immediate Release

Washington, DC – November 15, 2018

Avenu Medical Unveils Ellipsys – a Non-Surgical Fistula Creation System – with Live Simulcast Procedure at CiDA

Avenu’s Endovascular Arteriovenous Fistula (endoAVF®) Technology for ESRD Patients Receives Favorable Medicare Reimbursement Code while Exhibiting at Controversies in Dialysis Access Meeting

For Immediate Release

San Juan Capistrano, CA – June 26, 2018

Avenu Medical Receives FDA Approval for Ellipsys Vascular Access System for Non-Surgical Dialysis Fistula Creation Vascular Access System

Breakthrough Endovascular Arteriovenous Fistula (endoAVF®) Technology Approved for Hemodialysis Access

For Immediate Release

San Juan Capistrano, CA – June 1, 2016

Avenu Medical Receives CE Mark Approval for the Ellipsys® Vascular Access System

Company also completes full patient enrollment for pivotal Phase III clinical trial in the United States

Start typing and press Enter to search